Paydirt
BB
Insider

Bruce Booth

Director · Kymera Therapeutics

Bruce Booth (Director) filed 11 Form 4 reports in the trailing twelve months (0 purchases, 11 sales, 1 filed past the two-business-day deadline), most often in Kymera Therapeutics, Inc. (KYMR). The largest single filing was $56.3M of KYMR (511,764 sh across 27 lots, as filed), executed Jun 26. Data as of Nov 8 2026.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
11
0 buys · 11 sells · 1 late
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$224.9M
shares × price, as filed
Last traded
Jun 29
Filed Jul 2

Median ADV $102.3M across their filed names

Open performance→
Volume by month
$186.4M$93.2M$0Dec 2024Jun 2025Dec 2025Jun 2026Feb 2025 · buys $1.1MOct 2025 · sells $21.7MDec 2025 · sells $21.5MMar 2026 · sells $7.4MApr 2026 · sells $1.4MJun 2026 · sells $186.4MJul 2026 · sells $8.2M
Buys $1.1M Sells $246.6M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 11 filings

Sector per market data · by filing · past 12 months

Most traded names
KYMR Kymera Therapeutics, Inc. KYMR · 0 buys · 11 sells 11 filings SION Sionna Therapeutics, Inc. SION · 1 buy · 5 sells 6 filings
Recent filings
SIONPURCHASE Sionna Therapeutics, Inc. View filing → $1.1M
60,000 sh × $18.00
Exec Feb 10 2025
Filed Feb 10 2025 · 5:30 PM ET